IE 11 is not supported. For an optimal experience visit our site on another browser.

bc-Health-Robotics 05-10

/ Source: The Associated Press

bc-Health-Robotics 05-10



1/8SU3/8 PDT TRI


Health Robotics' i.v.STATION Certified as the Only Robot to Comply with

Security Guidelines for Controlled Substances

BOZEN, SUD-TIROL, Italy, May 10, 2010 /PRNewswire/ -- Health Robotics

today announced i.v.STATION's certification achieving compliance with a host

of global security guidelines for controlled substances, including

tamper-evident syringe caps, biometric identification, restricting nursing

access only to ready-to-administer IVs, single-dose storage and retrieval,


"In addition to being the only company in the world proven to use

Robotics to manufacture chemotherapy, monoclonal antibody therapy and gene

therapy ready-to-administer patient doses, we once again lead the market,

this time within the controlled substances drug class. I designed i.v.STATION

to automatically cap syringes with a B. Braun TEC1000 tamper-evident cap,

enhancing medication safety while reducing waste. Whereas this is arguably a

desirable feature for all medications, it is mandatory for controlled

substances in almost every country in the world. With i.v.STATION's unique

security features, unused syringes can be safely returned to the pharmacy and

re-dispensed. i.v.STATION fills a syringe and secures it with a luer-lock

twist cap, ensuring the integrity of the contents. The cap unlocks, just

prior to syringe use, by pulling the clear protective barrier off and

removing the red syringe cap. Other distinct advantages of i.v.STATION's

design over its competitors is the fact that it is the only robot to: a)

utilize biometric identification (facial recognition) as opposed to other

robots' use of simple ID/password combinations; and b) store each controlled

substance drug vial and each ready-to-administer syringe on its unique slot

for secure retrieval instead of outputting all doses to an open and unsecured

bucket mixing multiple IV doses of controlled substances with multiple IV

doses of other medications" stated Gaspar DeViedma, Health Robotics'

Executive V.P.

Diversion of controlled substances is recognized as a critical problem in

the United States. Healthcare professionals have easy access to controlled

substances, and according to the National Council of State Boards of Nursing,

approximately 15% of healthcare professionals struggle with drug dependence.

Drug diversion at hospitals can occur with PRNs 1/8when part or none of the

medication is given to the patient exactly on schedule during the shift3/8. A

nurse who worked at the V.A Medical Center in Bedford, Somerville Hospital,

and Metro West Medical Center-Framingham was sentenced because she stole

numerous controlled substances from these hospitals. A few years ago, an

emergency room nurse at Champlain Valley Physician's Hospital, N.Y., stole a

number of controlled substances, including morphine and methadone, from the

hospital's pharmacy department and the ER's locked narcotics cabinet.

Additionally, removing injectable controlled substances from their container

and replacing them with saline is another form of drug diversion. A nurse at

Morehead Memorial Hospital, N.C., pleaded guilty to stealing morphine,

secretly swapping the clear liquid drug with water. Each time, the caps were

cut off syringes filled with meperidine and the drug was drained out. Later,

the nurse refilled the syringes with saline solution and glued the simple

syringe caps back on. Common diversion methods have been amply documented in

scientific literature1/813/8.

"i.v.STATION's combined and unique security features add significant

competitive advantages over its two competitors as both Baxa's IntelliFill

and IHS' RIVA robots utilize a plain Kendall syringe cap which is easily

subject to tampering, accidental spillages, and other problems. This means

not only patient safety advantages but also exponentially increasing our lead

on ROI as i.v.STATION can handle a lot more than antibiotics, heparin and

insulin, the only drug classes that our competitors have been proven to

support. I look forward to seeing the results that our global partners,

especially Health Robotics Canada and the recently announced McKesson

exclusive partnership 1/8

tm3/8 achieve in the North American market, as a direct result of this new

breakthrough and industry-first achievement for Health Robotics," stated

Werner Rainer, Health Robotics' CEO.

About Health Robotics:

Health Robotics is the undisputed global leading supplier of

life-critical intra-venous medication robots, providing healthcare facilities

in 5 continents with robotics technology and software automation solutions

deployed utilizing virtual high-availability technology. Its world-leading

solutions CytoCare(TM) 1/8hazardous IVs3/8, i.v.STATION(TM) 1/8non-hazardous IVs3/8,

i.v.SOFT(TM) 1/8workflow engine for manual compounding, powered by

MEDarchiver3/8, and TPNstation(TM) 1/8totally-automated parenteral nutrition3/8

have and will greatly contribute to ease hospitals' growing pressures to

improve patient safety, increase throughput and contain costs. Through the

effective and efficient production of sterile, accurate, tamper-evident and

ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate

life-threatening drug-exchange errors, decrease other therapy oversights and

sterility risks, work more efficiently, reduce waste and controlled

substances' diversion, and diminish the gap between rising patient

volume/acuity and scarce nursing and pharmacy staff. For more information,

please visit

For additional information, please contact:

Health Robotics S.r.l.

Claudia Flaim

Marketing Coordinator

Italy: +39 0471.200.372



(Due to the length of these URLs, it may be necessary to copy and paste

the hyperlinks into your Internet browser's URL address field. Remove the

space if one exists.)

SOURCE Health Robotics

-0- 05/10/2010

/CONTACT: Health Robotics S.r.l., Claudia Flaim, Marketing Coordinator,

Italy: +39-0471-200-372,

CO: Health Robotics

ST: Italy




-- UKM655A --

8664 05/10/2010 08:59 EDT